South San Francisco-based Genentech turned down a buyout offer this week from Swiss drug giant Roche. We look at what a takeover might mean for the Bay Area’s leading biotech firm — and for the local life sciences industry.
Guests:
Marilyn Chase, staff reporter for the Wall Street Journal
Daniel Levine, web editor for the Journal of Life Science
Matthew Gardner, president and CEO of BayBio (Bay Area Bioscience Association)
Bob Erwin, president and founder of the Martin Nelson Foundation
Sponsored